The Supreme Court will pronounce on Monday its verdict in a landmark patent case involving Swiss pharma giant Novartis AG.

The company has challenged the denial of patent to its blood cancer drug Glivec in India The verdict, which is crucial even for public health, is being watched closely by global pharmaceutical firms, who have been pushing for stronger patent protection in India to regulate the country's $26-billion generic drug industry.

Vernon Hugh Bowman, a 75-year old Indiana farmer, says that switching to Monsanto Inc.'s "Roundup Ready" soybeans "made things so much simpler and better." Monsanto's patented beans can survive whe

A technology called a ‘terminator’ was never going to curry much favour with the public. But even Monsanto, the agricultural biotechnology giant in St Louis, Missouri, was surprised by the furore that followed when it patented a method for engineering transgenic crops to produce sterile seed, forcing farmers to buy new seed for each planting. In 1999, Monsanto’s chief executive pledged not to commercialize terminator seeds.

A freewheeling and almost entirely one-sided argument at the Supreme Court on Tuesday indicated that the justices would not allow Monsanto’s patents for genetically altered soybeans to be threatene

Disputes over intellectual property rights can delay the spread of clean technologies to the developing world, but they are not wholly to blame.

There is something that Prime Minister Manmohan Singh has in common with US diplomats—or at least the intellectual property (IP) attachés posted at various diplomatic missions: a dislike of NGOs. Both, the leader of the world’s most populous democracy and the diplomats of the most powerful democracy, make no bones about the fact that they find NGOs a stumbling block in implementing their various agendas.

Read More: http://www.downtoearth.org.in/content/menacing-us-diplomacy

Biopiracy is a compound word consisting of ‘bio’ which is a short form for ‘biology’ and ‘piracy’. Biopirates are those
individuals and industries/companies accused of one or both of the following acts: (i) the theft, misappropriation of, or

Why don't you sell it for Rs.5?

As India plays host to the Convention on Biological Diversity's 11th Conference of the Parties in Hyderabad in October 2012, this article takes a closer look at the country's legislation on the subject - the Biological Diversity Act (2002).

Open source drug discovery offers potential for developing new and inexpensive drugs to combat diseases that disproportionally affect the poor. The concept borrows two principle aspects from open source computing (i.e., collaboration and open access) and applies them to pharmaceutical innovation. By opening a project to external contributors, its research capacity may increase significantly. To date there are only a handful of open source R&D projects focusing on neglected diseases.

Pages